Best Rehabs with Ibogaine-Assisted Treatment in Canada

More About Ibogaine-Assisted Treatment

Much of the conversation about mental health treatment in the United States is circling around the use of psychedelics as potential treatment options for substance use disorders and mental health conditions. Ibogaine is one of those psychedelics that has garnered more attention over the years, and having more information about how it fits into this conversation can be helpful for those looking for newer treatment options.

What Is Ibogaine?

Ibogaine is a naturally-occurring compound that is derived from the root bark of the Tabernanthe iboga plant, an African shrub native to West Africa.^1,2 Historically, ibogaine has been used by religious groups in West and Central Africa for its psychedelic effects, as well as a for stimulant and appetite depressant purposes.² It is not believed to possess much addiction potential, therefore it is not considered a substance of misuse like cocaine, heroin, prescription drugs, or other addictive substances are.³

Today, ibogaine is being studied as a possible treatment option for people struggling with addiction and certain mental health conditions, and is in the beginning stages of clinical research.³

What is Ibogaine-Assisted Treatment?

Ibogaine-assisted treatment is not offered in the United States, as it has not received FDA-approval at this time. However, other countries, such as Mexico, New Zealand, and Brazil, are currently offering ibogaine-assisted treatment, as federal regulations are not as stringent and/or its not included in drug laws.

In these and other countries, ibogaine is being used to:

• Reduce opioid withdrawals and cravings.
• Support abstinence from alcohol use.
• Improve symptoms associated with mental health conditions like depression and anxiety.

When ibogaine is administered as a treatment, it begins to break down into a metabolite called noribogaine, which is believed to interact with several brain pathways involved in addiction, including those related to serotonin.⁴ Some clinics describe this process as an "addiction interrupter," since some patients report that a single dose may ease withdrawal symptoms and reduce cravings for opioids and other substances.

It is important to remember that despite these reported outcomes, Ibogaine treatment is still considered an emerging approach and caution should be exercised.

A Developing (Potential) Treatment

Most available evidence of ibogaine’s effectiveness comes from observational and open-label studies rather than large randomized controlled trials, including a systematic review of 24 studies and more than 700 participants that found consistent reductions in withdrawal symptoms and cravings.³ However, separate clinical safety research has identified real cardiac risks associated with ibogaine, including sudden cardiac death and changes to the heart's electrical activity, which is why medical screening and continuous monitoring are considered standard practice at reputable centres.⁵

Ibogaine remains a Schedule I controlled substance in the United States and is still in the very early stages of seeking possible FDA-approval. At this time, it has not gone through the same large-scale clinical trial process as many conventional addiction treatments have.⁴

Who Ibogaine May Help

Much more research needs to be conducted before it is fully determined who ibogaine may help most. The research that has been conducted, however, supports that it may be effective in treating those who:

• Have opioid use disorder, especially those who haven't found lasting relief through other withdrawal management approaches; observational studies have reported reduced withdrawal symptoms and drug cravings in this group.⁴
• Have cocaine, stimulant, or alcohol use disorders.
• With co-occurring depression, anxiety, or post-traumatic stress alongside substance use.
• Are veterans and first responders exploring options for trauma-linked substance use.
• Have tried other treatments without lasting success and want to explore additional options for addiction recovery.

Ibogaine-assisted treatment is currently not approved in the United States. If you encounter a treatment facility in the U.S. that is offering ibogaine as a therapeutic option, it is a major red flag, as doing so is illegal.

Also, clinical safety studies have excluded people with significant heart, liver, or kidney conditions, people who are pregnant, and people taking other medications that also affect heart rhythm, since ibogaine can affect the heart's electrical activity.⁵ Therefore, there is no research available to support ibogaine therapy as being safe for these and potentially other populations.

What to Expect

Since ibogaine-assisted therapy is not offered in the United States or on a large, worldwide scale, determining exactly what to expect for this specific treatment is not currently possible. However, when seeking therapy for a condition like a substance use disorder or mental health condition, the process is generally similar across the board and may include:

1. Performing an assessment. Before digging in to actual treatment, one or more medical and/or mental health providers will assess your current state. This includes obtaining basic physical and mental health history, along with determining why you are seeking therapy.
2. Developing a course of care: An individualized course of care is created based on factors such as what condition or conditions you are experiencing and what your mental state is. This plan is developed by your care team, which may include clinical providers who specialize in medical and mental health care.
3. Conducting sessions: You and your provider will determine the regularity of your therapy sessions and start scheduling them. He or she will inform you of what to expect during the sessions, including what to bring or not bring with you. From there, you will begin engaging in sessions for as long as you and your provider feel is best.

Since current findings report the potential of severe and potentially life-threatening cardiac complications when using ibogaine, it is reasonable to assume that those who do obtain ibogaine-assisted therapy internationally should do so under the close care and medical supervision of a licensed, experienced medical professional.

Related Treatment Approaches

• Medication-assisted treatment for opioid use — A more established, FDA-approved option that can ease opioid withdrawal and cravings, and one that many people compare with or use alongside ibogaine treatment.
• Cognitive behavioral therapy (CBT)— Often paired with ibogaine treatment during aftercare to help address the thought patterns that contribute to addiction.
• Eye movement desensitization and reprocessing (EMDR) — A trauma-focused therapy frequently recommended alongside ibogaine treatment for people with co-occurring post-traumatic stress.

Cost and Insurance

For residents of the United States, insurance will not offer coverage for ibogaine-assisted treatment because it does not have FDA-approval. However, international residents may have different opportunities in terms of utilizing insurance for this specific type of treatment.

If you are international, consider calling and speaking with a representative at your insurance company. They can inform you of the specifics of your personal plan, including what services may be able to be covered and which ones might be out-of-pocket.

Get Help For Yourself or A Loved One Today

Recovery may seem daunting, but effective help is available. Explore residential drug rehabs or specialized alcohol addiction treatment programs to find the right environment for healing. Use our free tool to search for mental health treatment and additional addiction treatment options by insurance, location, and amenities now.

Sources

1. National Institute on Drug Abuse. (2025). Drugs A to Z: Ibogaine.
2. UC Berkeley Centre for the Sciences of Psychedelics. (2026). Ibogaine.
3. 2. Köck, P., Froelich, K., Walter, M., Lang, U., & Dürsteler, K. M. (2022). A systematic literature review of clinical trials and therapeutic applications of ibogaine. Journal of Substance Abuse Treatment, 138, 108717.
4. Ali, S., Tian, X., Cunningham, K. A., & Zhou, J. (2025). Old dog, new tricks: Ibogaine and its analogs as potential neurotherapeutics. Journal of Medicinal Chemistry, 68(18), 18744–18751.
5. Knuijver, T., Schellekens, A. F. A., Belgers, M. H. M., Donders, A. R. T., van Oosteren, A. A., Kramers, C., & Verkes, R. J. (2022). Safety of ibogaine administration in detoxification of opioid-dependent individuals: A descriptive open-label observational study. Addiction, 117(1), 118–128.